Drugs / Purified Exosome Product
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06793748 | Jun → Nov 2025 overdue | chronic ulcer of skin | Rion Inc. | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Purified Exosome Product | “Purified Exosome Product (PEP™) and Fibrin Sealant (TISSEEL® VH SD Kit) (Biologic) (PEP-TISSEEL)” NCT06793748 ↗ |
| Known as | PEP | “Purified Exosome Product (PEP™) and Fibrin Sealant (TISSEEL® VH SD Kit) (Biologic) (PEP-TISSEEL)” NCT06793748 ↗ |
| Route | Topical | “Participants in the PEP-TISSEEL group will receive 1 topical application per week” NCT06793748 ↗ |